311 related articles for article (PubMed ID: 21748243)
1. Plasma paraoxonase-1, oxidized low-density lipoprotein and lipid peroxidation levels in gout patients.
Jiang XL; Li M; Zhou JG; Yang QB; Du LJ; Du J
Cell Biochem Biophys; 2011 Nov; 61(2):461-6. PubMed ID: 21748243
[TBL] [Abstract][Full Text] [Related]
2. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
[TBL] [Abstract][Full Text] [Related]
3. Serum paraoxonase phenotype distribution in exudative age-related macular degeneration and its relationship to homocysteine and oxidized low-density lipoprotein.
Javadzadeh A; Ghorbanihaghjo A; Bahreini E; Rashtchizadeh N; Argani H; Alizadeh S
Retina; 2012 Apr; 32(4):658-66. PubMed ID: 22030834
[TBL] [Abstract][Full Text] [Related]
4. Assessment of paraoxonase activity and lipid peroxidation levels in diabetic and senile subjects suffering from cataract.
Hashim Z; Zarina S
Clin Biochem; 2007 Jun; 40(9-10):705-9. PubMed ID: 17466963
[TBL] [Abstract][Full Text] [Related]
5. Effect of oxidative stress on antioxidant enzyme activities, homocysteine and lipoproteins in chronic kidney disease.
Atamer A; Kocyigit Y; Ecder SA; Selek S; Ilhan N; Ecder T; Atamer Y
J Nephrol; 2008; 21(6):924-30. PubMed ID: 19034878
[TBL] [Abstract][Full Text] [Related]
6. Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients.
Yavuz DG; Yüksel M; Deyneli O; Ozen Y; Aydin H; Akalin S
Clin Endocrinol (Oxf); 2004 Oct; 61(4):515-21. PubMed ID: 15473886
[TBL] [Abstract][Full Text] [Related]
7. PON1, a new biomarker of cardiovascular disease, is low in patients with systemic vasculitis.
Quéméneur T; Martin-Nizard F; Kandoussi A; Kyndt X; Vanhille P; Hachulla E; Hatron PY; Fruchart JC; Duriez P; Lambert M
Semin Arthritis Rheum; 2007 Dec; 37(3):149-55. PubMed ID: 17512573
[TBL] [Abstract][Full Text] [Related]
8. Serum oxidized low density lipoprotein, paraoxonase 1 and lipid peroxidation levels during oral glucose tolerance test.
Serin O; Konukoglu D; Firtina S; Mavis O
Horm Metab Res; 2007 Mar; 39(3):207-11. PubMed ID: 17373636
[TBL] [Abstract][Full Text] [Related]
9. Association of oxidative stress and PON1 with LDL and HDL particle size in middle-aged subjects.
Vekic J; Kotur-Stevuljevic J; Jelic-Ivanovic Z; Spasic S; Spasojevic-Kalimanovska V; Topic A; Zeljkovic A; Stefanovic A; Zunic G
Eur J Clin Invest; 2007 Sep; 37(9):715-23. PubMed ID: 17696961
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress in white coat hypertension; role of paraoxonase.
Uzun H; Karter Y; Aydin S; Curgunlu A; Simşek G; Yücel R; Vehiyd S; Ertürk N; Kutlu A; Benian A; Yaldiran A; Oztürk E; Erdine S
J Hum Hypertens; 2004 Jul; 18(7):523-8. PubMed ID: 14985779
[TBL] [Abstract][Full Text] [Related]
11. Circulating oxidized low-density lipoprotein and paraoxonase activity in preeclampsia.
Uzun H; Benian A; Madazli R; Topçuoğlu MA; Aydin S; Albayrak M
Gynecol Obstet Invest; 2005; 60(4):195-200. PubMed ID: 16088195
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress and enzymatic antioxidant status in patients with hypothyroidism before and after treatment.
Baskol G; Atmaca H; Tanriverdi F; Baskol M; Kocer D; Bayram F
Exp Clin Endocrinol Diabetes; 2007 Sep; 115(8):522-6. PubMed ID: 17853336
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease].
Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):289-93. PubMed ID: 16767666
[TBL] [Abstract][Full Text] [Related]
14. Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis.
Asefi M; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Nomani H; Ebrahimi A; Tavilani H; Pourmotabbed T
Br J Dermatol; 2012 Dec; 167(6):1279-86. PubMed ID: 22835076
[TBL] [Abstract][Full Text] [Related]
15. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
[TBL] [Abstract][Full Text] [Related]
16. Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatin.
Samy W; Hassanian MA
Arab J Gastroenterol; 2011 Jun; 12(2):80-5. PubMed ID: 21684478
[TBL] [Abstract][Full Text] [Related]
17. The role of oxidative stress and antioxidant defenses in Buerger disease and atherosclerotic peripheral arterial occlusive disease.
Arslan C; Altan H; Beşirli K; Aydemir B; Kiziler AR; Denli S
Ann Vasc Surg; 2010 May; 24(4):455-60. PubMed ID: 19128930
[TBL] [Abstract][Full Text] [Related]
18. Paraoxonase 1 gene polymorphisms, paraoxonase/arylesterase activities and oxidized low-density lipoprotein levels in patients with migraine.
Yıldırım S; Akar S; Kuyucu M; Yıldırım A; Dane S; Aygül R
Cell Biochem Funct; 2011 Oct; 29(7):549-54. PubMed ID: 21755523
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant status and oxidative stress markers in pancreatic cancer and chronic pancreatitis.
Kodydkova J; Vavrova L; Stankova B; Macasek J; Krechler T; Zak A
Pancreas; 2013 May; 42(4):614-21. PubMed ID: 23558240
[TBL] [Abstract][Full Text] [Related]
20. Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia.
Marsillach J; Martínez-Vea A; Marcas L; Mackness B; Mackness M; Ferré N; Joven J; Camps J
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):347-9. PubMed ID: 17324148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
